Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein.

業績番号：2002-1

A.Suzuki, K.Obi, T.Urabe, H.Hayakawa, M.Yamada, S.Kaneko, M.Onodera, Y.Mizuno and H.Mochizuki.

Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein.

Journal of Neurochemistry 82; 953:960; 2002

12358801

https://doi.org/10.1046/j.1471-4159.2002.01048.x